GREGORIAN VARTAN

CIK 00011985591 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001198559

Recent Transactions

42 trades

Sale
CTI BIOPHARMA CORP
Common Stock
2014-03-28$3.41/sh−55,000→ 488,937 total
Sale
CTI BIOPHARMA CORP
Common Stock
2014-03-28$3.40/sh−900→ 550,037 total
Sale
CTI BIOPHARMA CORP
Common Stock
2014-03-28$3.42/sh−20,000→ 468,937 total
Sale
CTI BIOPHARMA CORP
Common Stock
2014-03-28$3.40/sh−5,900→ 543,937 total
Sale
CTI BIOPHARMA CORP
Common Stock
2014-03-28$3.40/sh−200→ 549,837 total
Award
CTI BIOPHARMA CORP
Common Stock
2014-01-30+146,000→ 550,937 total
Award
CTI BIOPHARMA CORP
Stock Option (right to buy)
2013-12-10+100,000→ 100,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2013-06-26+86,957→ 404,937 total
Award
CTI BIOPHARMA CORP
Common Stock
2013-03-21+109,891→ 317,980 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2013-03-21−28,093→ 208,089 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-12-03+71,429→ 236,182 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-06-27+27,415→ 823,779 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-03-30$1.31/sh−7,600→ 821,497 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-03-30$1.32/sh−25,033→ 796,464 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-03-30$1.31/sh−44,167→ 829,097 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-03-30$1.30/sh−100→ 873,264 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+516,360→ 873,364 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−166,109→ 357,004 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-11-29+187,292→ 523,113 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-11-11+3,333→ 335,821 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2011-11-11+5,000→ 5,000 total
Award
CTI BIOPHARMA CORP
Restricted Stock Units
2011-03-21+125,000→ 125,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-03-21$0.43/sh+125,000→ 1,994,933 total
Award
CTI BIOPHARMA CORP
Common Stock
2011-03-21+125,000→ 1,994,933 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-28$0.37/sh−9,600→ 1,869,933 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-28$0.37/sh−26,800→ 1,879,533 total
Sale
CTI BIOPHARMA CORP
Common Stock
2010-12-28$0.37/sh−3,600→ 1,906,333 total
Award
CTI BIOPHARMA CORP
Common Stock
2010-09-16+20,000→ 1,909,933 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2010-09-16+30,000→ 30,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2010-07-12+996,661→ 1,889,933 total
Award
CTI BIOPHARMA CORP
Performance Rights
2009-12-15+440,251→ 440,251 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-11-13+290,017→ 893,272 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2009-10-20+30,000→ 30,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-10-20+20,000→ 603,255 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-07-31+214,966→ 583,255 total
Award
CTI BIOPHARMA CORP
Common Stock
2009-04-01+321,839→ 368,289 total
Award
CTI BIOPHARMA CORP
Common Stock
2008-10-22+40,000→ 46,450 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2008-06-19+36,000→ 36,000 total
Award
CTI BIOPHARMA CORP
Common Stock
2008-06-19+9,000→ 64,500 total
Award
CTI BIOPHARMA CORP
Common Stock
2006-12-10+2,500→ 10,000 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2006-12-10+12,000→ 12,000 total
Award
CTI BIOPHARMA CORP
Non-Qualified Stock Option (right to buy)
2006-02-17+17,000→ 17,000 total

Companies

CTI BIOPHARMA CORP
Director

Recent Filings

Address

501 ELLIOTT AVE WEST SUITE 400

SEATTLE, WA, 98119

View on SEC.gov